Establishment and characterisation of six human biliary tract cancer cell lines

Human cell lines established from biliary tract cancers are rare, and only five have been reported previously. We report the characterisation of six new six biliary tract cancer cell lines (designated SNU-245, SNU-308, SNU-478, SNU-869, SNU-1079 and SNU-1196) established from primary tumour samples of Korean patients. The cell lines were isolated from two extrahepatic bile duct cancers (one adenocarcinoma of common bile duct, one hilar bile duct cancer), two adenocarcinomas of ampulla of Vater, one intrahepatic bile duct cancer (cholangiocarcinoma), and one adenocarcinoma of the gall bladder. The cell phenotypes, including the histopathology of the primary tumours and in vitro growth characteristics, were determined. We also performed molecular characterisation, including DNA fingerprinting analysis and abnormalities of K-ras, p15, p16, p53, hMLH1, hMSH2, DPC4, β-catenin, E-cadherin, hOGG1, STK11, and TGF-βRII genes by PCR–SSCP and sequencing analysis. In addition, we compared the genetic alterations in tumour cell lines and their corresponding tumour tissues. All lines grew as adherent cells. Population doubling times varied from 48–72 h. The culture success rate was 20% (six out of 30 attempts). All cell lines showed (i) relatively high viability; (ii) absence of mycoplasma or bacteria contamination; and (iii) genetic heterogeneity by DNA fingerprinting analysis. Among the lines, three lines had p53 mutations; and homozygous deletions in both p16 and p15 genes were found three and three lines, respectively; one line had a heterozygous missense mutation in hMLH1; E-cadherin gene was hypermethylated in two lines. Since the establishment of biliary tract cancer cell lines has been rarely reported in the literature, these newly established and well characterised biliary tract cancer cell lines would be very useful for studying the biology of biliary tract cancers, particularly those related to hypermethylation of E-cadherin gene in biliary tract cancer.

[1]  Y. Chung,et al.  Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model. , 1995, British Journal of Cancer.

[2]  T. Kudo,et al.  Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. , 1995, The Tohoku journal of experimental medicine.

[3]  H. Shinohara,et al.  Disrupted transforming growth factor‐β signaling and deregulated growth in human biliary tract cancer cells , 2000, International journal of cancer.

[4]  J. Yokota,et al.  Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA , 1998, Oncogene.

[5]  M. A. Khan,et al.  Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. , 1997, Oncogene.

[6]  A. Gazdar,et al.  CHARACTERISTICS OF COLORECTAL CARCINOMA CELL LINES paraffin embedded sections of xenografts , 2006 .

[7]  M. Kojiro,et al.  Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC) , 1992, Cancer.

[8]  J. Minna,et al.  Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. , 1995, JAMA.

[9]  T. Sawada,et al.  Establishment and characterization of a new human gallbladder carcinoma cell line (OCUG-1) producing TA-4. , 1997, International journal of oncology.

[10]  Y. Nakamura,et al.  Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. , 1998, Cancer research.

[11]  R. Hruban,et al.  Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. , 1998, Cancer research.

[12]  P. Soballe,et al.  Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. , 1997, Cancer research.

[13]  Y. Nakamura,et al.  Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. , 1996, Journal of the National Cancer Institute.

[14]  G. Berx,et al.  E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. , 1996, Oncogene.

[15]  Y. Yuasa,et al.  Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. , 1996, Cancer research.

[16]  W. H. Kim,et al.  Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. , 2001, Cancer letters.

[17]  G. Tamura,et al.  Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (ICBD-1). , 1998, Oncology reports.

[18]  M. Williamson,et al.  p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. , 1995, Human molecular genetics.

[19]  Kathleen R. Cho,et al.  A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. , 1995, Cancer research.

[20]  K. Yeo,et al.  Characterization of cell lines established from human hepatocellular carcinoma , 1995, International journal of cancer.

[21]  Hyun Kim,et al.  Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross‐species color banding , 2001, Genes, chromosomes & cancer.

[22]  Mohammed A. Khan,et al.  Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β , 1997, Oncogene.

[23]  K. Kinzler,et al.  hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. , 1994, Cancer research.

[24]  J. Ku,et al.  Establishment and characterization of human laryngeal squamous cell carcinoma cell lines , 1999, The Laryngoscope.

[25]  M. Kelley,et al.  Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA , 1996, International Journal of Cancer.

[26]  J. Nezu,et al.  Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. , 1998, Nature genetics.

[27]  G. Hannon,et al.  Deletion of the p16 and p15 genes in human bladder tumors. , 1995, Journal of the National Cancer Institute.

[28]  W. Dippold,et al.  Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. , 1985, Journal of hepatology.

[29]  W. Schmiegel,et al.  Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. , 1998, Cancer research.

[30]  Hypermethylation of E-cadherin in leukemia. , 2000 .

[31]  S. Hanai,et al.  Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. , 1995, Cancer research.

[32]  P. Seeburg,et al.  Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations , 1983, Nature.

[33]  K. Miyazaki,et al.  Establishment and characterization of human hilar bile duct carcinoma cell line and cell strain. , 2000, Journal of hepato-biliary-pancreatic surgery.